Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Taxotere and Adriamycin/Cytoxan (AC) Validation in Breast Cancer Patients (TACAC)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Baylor College of Medicine
Information provided by (Responsible Party):
Baylor Breast Care Center
ClinicalTrials.gov Identifier:
NCT00206518
First received: September 14, 2005
Last updated: August 26, 2016
Last verified: August 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: September 2017
  Estimated Primary Completion Date: October 2016 (Final data collection date for primary outcome measure)